Different types of cell death and their interactions in myocardial ischemia-reperfusion injury

Bingxin Du1, Qiang Fu2, Qin Yang1

  • 1Department of Pharmacy, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Cell Death Discovery
|March 5, 2025
PubMed

Insights

Myocardial ischemia-reperfusion (I/R) injury involves multiple cell death types. Understanding these pathways and their interactions is key to developing cardio-protection strategies for heart disease.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Death Research

Background:

  • Myocardial ischemia-reperfusion (I/R) injury is a critical complication in coronary artery disease.
  • Cardiomyocyte cell death, including apoptosis, necroptosis, autophagy, pyroptosis, and ferroptosis, significantly contributes to I/R injury.
  • Preventing diverse cell death mechanisms is crucial for managing ischemic cardiomyopathy.

Purpose of the Study:

  • To comprehensively review the molecular mechanisms of five key cell death types in myocardial I/R injury.
  • To elucidate the crosstalk and interactions among these distinct cell death pathways.
  • To identify molecular targets for novel cardio-protective interventions.

Main Methods:

  • Literature review of molecular mechanisms in myocardial I/R injury.
  • Analysis of cell death pathways: apoptosis, necroptosis, autophagy, pyroptosis, and ferroptosis.
  • Examination of molecular targets and their roles in cell death regulation.

Main Results:

  • Multiple cell death types (apoptosis, necroptosis, autophagy, pyroptosis, ferroptosis) are involved in myocardial I/R injury.
  • These cell death pathways exhibit complex crosstalk and interactions.
  • Specific molecular targets regulate these distinct cell death processes.

Conclusions:

  • Understanding the interplay of different cell death mechanisms is vital for reducing myocardial I/R injury.
  • Targeting molecules involved in these pathways offers potential for developing cardio-protective therapies.
  • This review provides a foundation for future research into novel interventions for ischemic cardiomyopathy.